Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Azithromycine Pour la Vie Des Enfants au Niger - Implémentation et Recherche: Essai mortalité et résistance (Azithromycin for Child Survival in Niger: Mortality Trial and Resistance Trial)

NCT04224987 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT04224987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04224987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Azithromycine Pour la Vie Des Enfants au Niger - Implémentation et Recherche: Essai mortalité et résistance (Azithromycin for Child Survival in Niger: Mortality Trial and Resistance Trial)
Lead sponsor
University of California, San Francisco
Phase
Phase 4
Overall status
Completed
Start date
November 24, 2020
Completion date
July 31, 2024
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

child, only, mortality, resistance bacterial